OTCMKTS:HYPMYHYPERA S A/S Stock Price, Forecast & News

$6.19

+0.03 (+0.49 %)

(As of 08/13/2020 04:00 PM ET)

Add

Compare

Today's Range

$6.16

Now: $6.19▼

$6.29

50-Day Range

$5.87

MA: $6.34▼

$7.31

52-Week Range

$4.51

Now: $6.19▼

$9.53

Volume605,547 shs

Average Volume70,895 shs

Market Capitalization$3.91 billion

P/E Ratio14.40

Dividend Yield2.27%

Beta1.18

Hypera S.A. operates as a pharmaceutical company in Brazil. The company offers prescription medications under the Farmasa, Neo Química, and Luper brands; and over-the-counter medications comprising laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant, and other drugs under Gelol, Anapyon, Biotônico Fontoura, Epocler, Merthiolate, Tamarine, and Rinosoro brands. It also provides similars and generics under the Neo Química brand; dermocosmetics under the Lanidrant, Agecare, Dersab, Epidac, Epidrat, Episol, Hidramamy, Creme rejuvenecedor, Blancy, and Pielus brands; and food supplements and sweeteners. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. The company was founded in 2001 and is headquartered in São Paulo, Brazil.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for HYPERA S A/S.

2.6 Community Rank

Outperform Votes
HYPERA S A/S has received 155 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
HYPERA S A/S has received 142 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
HYPERA S A/S has received 52.19% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about HYPERA S A/S and other stocks. Vote “Outperform” if you believe HYPMY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HYPMY will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.8 Dividend Strength

Dividend Yield
HYPERA S A/S pays a meaningful dividend of 2.27%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
HYPERA S A/S does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, HYPERA S A/S insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.22% of the stock of HYPERA S A/S is held by institutions.

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of HYPERA S A/S is 14.40, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 17.46.
Price to Earnings Ratio vs. Sector
The P/E ratio of HYPERA S A/S is 14.40, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.21.
Price to Book Value per Share Ratio
HYPERA S A/S has a P/B Ratio of 1.77. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

0.94 out of 5 stars

Industry, Sector and Symbol

Stock Exchange OTCMKTS

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolOTCMKTS:HYPMY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.hyperapharma.com.br

Phone55-11-3627-4206

Debt

Debt-to-Equity Ratio0.16

Current Ratio2.99

Quick Ratio2.55

Price-To-Earnings

Trailing P/E Ratio14.40

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$834.89 million

Price / Sales4.69

Cash Flow$0.52 per share

Price / Cash Flow11.93

Book Value$3.49 per share

Price / Book1.77

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$294.97 million

Net Margins29.26%

Return on Equity12.77%

Return on Assets9.77%

Miscellaneous

Employees7,515

Outstanding Shares632,240,000

Market Cap$3.91 billion

Next Earnings Date8/17/2020 (Estimated)

OptionableNot Optionable

$6.19

+0.03 (+0.49 %)

(As of 08/13/2020 04:00 PM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive HYPMY News and Ratings via Email

Sign-up to receive the latest news and ratings for HYPMY and its competitors with MarketBeat's FREE daily newsletter.

HYPERA S A/S (OTCMKTS:HYPMY) Frequently Asked Questions

How has HYPERA S A/S's stock price been impacted by COVID-19?

HYPERA S A/S's stock was trading at $6.98 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HYPMY shares have decreased by 11.3% and is now trading at $6.19.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of HYPERA S A/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HYPERA S A/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for HYPERA S A/S.

When is HYPERA S A/S's next earnings date?

HYPERA S A/S is scheduled to release its next quarterly earnings announcement on Monday, August 17th 2020.
View our earnings forecast for HYPERA S A/S.

How often does HYPERA S A/S pay dividends? What is the dividend yield for HYPERA S A/S?

HYPERA S A/S declared a quarterly dividend on Monday, September 30th. Stockholders of record on Thursday, October 10th will be given a dividend of $0.04 per share on Friday, February 7th. This represents a $0.16 annualized dividend and a yield of 2.58%. The ex-dividend date of this dividend is Wednesday, October 9th.
View HYPERA S A/S's dividend history.

Has HYPERA S A/S been receiving favorable news coverage?

Media coverage about HYPMY stock has trended extremely negative on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. HYPERA S A/S earned a news impact score of -4.1 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near future.
View the latest news about HYPERA S A/S.

Are investors shorting HYPERA S A/S?

HYPERA S A/S saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 1,000 shares, a drop of 37.5% from the June 15th total of 1,600 shares. Based on an average daily trading volume, of 108,000 shares, the short-interest ratio is presently 0.0 days.
View HYPERA S A/S's Short Interest.

Who are some of HYPERA S A/S's key competitors?

Some companies that are related to HYPERA S A/S include Horizon Therapeutics (HZNP), Catalent (CTLT), Teva Pharmaceutical Industries (TEVA), Sarepta Therapeutics (SRPT), GRIFOLS S A/S (GRFS), GALAPAGOS NV/S (GLPG), Elanco Animal Health (ELAN), Dr.Reddy's Laboratories (RDY), Ono Pharmaceutical (OPHLF), Mylan (MYL), Ascendis Pharma A/S (ASND), Ionis Pharmaceuticals (IONS), Perrigo (PRGO), Emergent Biosolutions (EBS) and Jazz Pharmaceuticals (JAZZ).
View all competitors.

Who are HYPERA S A/S's key executives?

HYPERA S A/S's management team includes the following people:

Mr. Breno Toledo Pires de Oliveira, Chief Exec. Officer
Ms. Vivian Angiolucci, Chief Financial Officer
Mr. Carlos Roberto Scorsi, Chief Operating officer (Age 57)
Juliana Aguinaga Damião Salem, Chief Legal & Compliance Officer
Mr. Nelson José de Mello, Chief Corp. Relations Officer (Age 60)

What is HYPERA S A/S's stock symbol?

HYPERA S A/S trades on the OTCMKTS under the ticker symbol "HYPMY."

How do I buy shares of HYPERA S A/S?

Shares of HYPMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is HYPERA S A/S's stock price today?

One share of HYPMY stock can currently be purchased for approximately $6.19.

How big of a company is HYPERA S A/S?

HYPERA S A/S has a market capitalization of $3.91 billion and generates $834.89 million in revenue each year. HYPERA S A/S employs 7,515 workers across the globe.

What is HYPERA S A/S's official website?

The official website for HYPERA S A/S is www.hyperapharma.com.br.

How can I contact HYPERA S A/S?

HYPERA S A/S's mailing address is AV. MAGALHAES DE CASTRO 4800 - 24¿ ANDAR EDIFICIO CONTINENTAL TOWER, SAO PAULO D5, 05676-120. The company can be reached via phone at 55-11-3627-4206 or via email at [email protected]

This page was last updated on 8/13/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings